GSE185760
RNA-Seq of MDA-MB-231 human triple-negative breast cancer cells treated with a copper chelator
We report the application of RNA-sequencing of MDA-MB-231 human triple-negative breast cancer cells treated with copper chelator Tetraethylenepentamine (TEPA) for 8 and 24 hours. We show transcriptome changes following copper chelation vs. control untreated cells.vs. control samples Overall design: MDA-MB-231 human triple-negative breast cancer cells treated with copper chelator TEPA (8 mM) for 8 and 24 hours in vitro